Offstream
news

Changes

1. Brazilian drug regulator Anvisa approves the use of the Sinovac's Coronavac vaccine for children aged between 6 to 11 years.
   2022-01-21 01:06:16 (First version)
2. Brazilian drug regulator Anvisa approves the use of the Sinovac CoronaVac vaccine for children between the ages of 6 and 11 years.
   (Current version)

Related